Navigation Links
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Date:7/29/2009

i>

There can be no assurance that we will conduct additional CMV studies in the future. The FDA or other regulatory authorities may prohibit any future studies with maribavir or alternatively may require additional or unanticipated studies or clinical trial outcomes before granting regulatory approval. There can be no guarantee that we will be successful in gaining regulatory approval of maribavir for any indications. There can be no assurance that we will conduct additional studies with for acute treatment of HAE or that we will be successful in gaining regulatory approval of Cinryze for additional indications, formulations or in additional territories. In addition, approval of a competing product which has been granted orphan drug designation would prevent Cinryze from reaching the market for acute treatment of HAE. There can be no assurance that the FDA or EMEA will not require additional or unanticipated studies or clinical trial outcomes before granting regulatory approval of any of our product candidates, or that we will be successful in gaining regulatory approval of any of our product candidates. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K for the year ended December 31, 2008 and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.

                              VIROPHARMA INCORPORATED
                       Selected Financial Information- GAAP

    Consolidated Statements of Operations:
    (in thousands, except per           Three months ended   Six months ended
     share 
'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
2. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
3. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
4. ViroPharma to Present at Two May Healthcare Conferences
5. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
6. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
7. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. ViroPharma Provides Update on Vancocin(R)
11. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Topical BioMedics, Inc., announces its May Pain Management Webinar will ... streamed live and then archived and accessible on demand 24/7. ... clicking on the following link: http://bit.ly/PMW_FIBRO . ... the webinar, and questions may also be submitted in advance ... the May webinar is “What You need to Know about ...
(Date:5/6/2015)... Cloud security companies Sookasa Inc ... partnership to help small-to-medium businesses secure their sensitive data ... are teaming up to transition SafeMonk customers to Sookasa’s ... to welcome SafeMonk users to the Sookasa family, and ... SafeMonk, the global powerhouse SafeNet (now Gemalto IDSS), are ...
(Date:5/6/2015)... Arizona (PRWEB) May 06, 2015 ... IMMEDIATE RELEASE , Med Ag Ventures, Inc. (MAV), ... manufacturing capacity of its Arizona based Phoenician Engineering ... grinders last September. MAV recently achieved profitability from ... network expanded from 100 at the end of ...
(Date:5/6/2015)... Hope For The Warriors® and American ... at the New York Athletic Club on April 21, ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... local and nationwide military families. The Barry Fixler Foundation/Semper ...
(Date:5/6/2015)... 06, 2015 The Jefferson Awards ... to activating and celebrating public service, announced today ... Health, as an Outstanding Employee Volunteer Organization. Champions ... Awards Foundation, are dedicated to building a culture ... decade, Highmark Health has recognized employees who volunteer ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:4th Annual Casino Night Draws Support for Military Families in New York City Region 2Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4
... economy has been "seizing" uncontrollably. Now a Tel Aviv ... economic downturn with the uncontrolled spasms of an epileptic ... the origins of the disaster. In a recent ... Ben-Jacob of Tel Aviv University,s School of Physics and ...
... released online today, a majority of Americans, including most African ... just as other cigarette flavorings have now been banned by ... African American smokers and 24 percent of white smokers smoke ... by the Center for Child and Adolescent Health Policy at ...
... , THURSDAY, May 12 (HealthDay News) -- Italian researchers ... may actually suffer from a psychological condition known as ... is deficient in the enzyme lactase, which breaks down ... bloating, gas, gut pain and nausea when they eat ...
... Researchers at the Stanford University School of Medicine ... naturally occurring "tumor-suppressor" protein works. The separation of these ... could enhance efforts to develop treatment approaches that ... The protein, p53, is mutated or missing in ...
... May 12 (HealthDay News) -- Mind-body therapies such as yoga, ... in mainstream medicine, according to a new study. ... and that number is rising, the researchers noted. They found ... therapy was referred to the treatment by a medical provider. ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, May 11 ... adults with attention-deficit hyperactivity disorder (ADHD), or the parents of ... finding one that carries the prescription they need to manage ... vary, but much of the focus has been on Adderall ...
Cached Medicine News:Health News:Diagnosing 'seizures' in the US economy 2Health News:African Americans and the general public support banning menthol in cigarettes 2Health News:Lactose Intolerance May Sometimes Be in the Head, Not the Gut 2Health News:Stanford discoveries about tumor-suppressing protein could help to reduce treatment side effects 2Health News:Stanford discoveries about tumor-suppressing protein could help to reduce treatment side effects 3Health News:Doctors Prescribing Meditation, Yoga More Often 2Health News:ADHD Drug Shortage Has Patients, Parents Scrambling 2Health News:ADHD Drug Shortage Has Patients, Parents Scrambling 3
(Date:5/6/2015)... , May 6, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the Bank of America Merrill Lynch 2015 ... a.m. Pacific time from the Encore at the Wynn in ... the presentation can be accessed at www.meipharma.com . A ...
(Date:5/6/2015)... , May 6, 2015  TriStar Wellness Solutions(R), ... that targets opportunities in the advanced wound care ... Oregon based wholly owned independent subsidiary ... funding from the National Institutes of Health (NIH) ... that is able to be delivered by a ...
(Date:5/6/2015)... , May 6, 2015  Genomic Health, Inc. (Nasdaq: ... , Chairman of the Board, Chief Executive Officer & ... Lynch 2015 Healthcare Conference in Las Vegas ... Pacific Time (PT). To access the live ... the  Investor Relations  section of the company,s web site ...
Breaking Medicine Technology:MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 3Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 4Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 5Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 2Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 3
... , , ROSH ... of innovative solutions for the advanced chronic,wound management market, ... Food and Drug Administration (FDA) to market its new,SilverStream(TM) ... Over-the-Counter version of the SilverStream product. , ...
... , , , , ... NXTM ), a leading manufacturer of innovative dialysis products, ... and their partners will be embarking on a week-long, conventional ... The cruise, dubbed the "2010 Freedom Cruise: We,re Taking Home ...
Cached Medicine Technology:EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4
... refrigerator is specially designed ... blood in standard 500ml ... Standard AS3864 1997. Quiet ... utilising CFC Free refrigerant ...
TBR-720-2-GD is large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standard AS38...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... circulating testosterone exists as unbound or free ... to SHBG with high affinity [1], while ... Both the albumin-bound and free fractions may ... testosterone action. Measurement of the free or ...
Medicine Products: